Background Both benign prostatic hyperplasia (BPH) and Type-1 diabetes mellitus (T1DM)
share similar epidemiologic features and are all associated with the insulin-like growth factor …

Objective Emerging evidence has suggested that physical activities can reduce the risk of
benign prostatic hyperplasia (BPH). Here, we evaluated the effect of aerobic exercise in a …

This study investigated the changes in the prostate of high-fat diet (HFD)-fed mice with
insulin resistance (IR) and explored the possible mechanisms of the effects of 8-week …

Introduction. Clinical observation of larger prostate glands in men with diabetes mellitus type
2 led some investigators to hypothesize that an association between these two conditions …

BACKGROUND Obesity, dyslipidemia, Hyperinsulinemia, and insulin resistance (IR) are key
features of metabolic syndrome and are considered as risk factors for benign prostatic …

Diabetes significantly increases the risk of benign prostatic hyperplasia (BPH) and low
urinary tract symptoms (LUTS). The major endocrine aberration in connection with the …

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are
highly prevalent in older men and represent a substantial challenge to public health …

Objective: To investigate whether metabolic syndrome (MetS) may be associated with the
clinical progression of benign prostatic hyperplasia (BPH). Methods: A total of 525 …

Testosterone (T) plays a permissive role in the development of benign prostatic hyperplasia
(BPH), and phosphodiesterase 5 inhibitors (PDE5is) have been found to be effective for …

PURPOSE Benign prostatic hyperplasia (BPH) is a very common urological disease in older
men, and it typically leads to lower urinary tract symptoms (LUTS). The exact cause of BPH …